Pomegranate juice could be the next estrogen-responsive breast cancer treatment. A new lab study has demonstrated promising results when evaluating the use of pomegranate juice, a juice rich in antioxidants, as a way of fighting off and preventing breast cancer.
More than 75 percent of all breast cancer cases are fed by estrogen and there are over 400,000 women dieing annually, around the world, from breast cancer. Researchers with Ohio State University focused on the benefits of pomegranates in the breast cancer fight. The team discovered the large red fruit filled with juicy seeds naturally produces a chemical known as ellagic acid, which seems to help slow and even prevent the growth of cancer cells in breast tissue.
According to researchers, the pomegranate has recently been noted for its antioxidants and potential cancer fighting attributes, as well as its heart healthy benefits. However, the study recently published in Cancer Prevention Research is the first to take a look at the affects of the pomegranate on breast cancer and aromatase, an enzyme that plays a key role in making estrogen and promoting the growth of breast cancer.
In a lab, the team studied the effects of ten ellagitannin-derived compounds produced by pomegranates, which are thought to potentially prevent estrogen-related breast cancer. They considered the effects of the ten compounds on the growth of breast cancer cells and aromatase activity. Of the ten ellagitannin-derived compounds studied, the researchers discovered urolithin B was the standout in the fight against breast cancer.
No comments:
Post a Comment